Genomes are duplicated with a very high degree of accuracy every cell cycle. This challenging task is made more difficult by a variety of intrinsic and extrinsic agents that interrupt DNA replication. Replication forks can encounter many endogenous blocks such as transcription complexes and DNA repair machinery. External agents such as ultraviolet radiation, which produces a variety of base modificationsmainly pyrimidine dimers -and hydroxyurea, which depletes the deoxyribonucleotide triphosphate (dNTP) pool by inhibiting ribonucleotide reductase, potently impede replication fork progression. To cope with these difficulties, cells have a DNA replication monitoring system that senses stalled replication forks and directs various responses. One of these responses is the S-M checkpoint that delays the onset of mitosis (M) while DNA synthesis (S) is underway. This cell cycle checkpoint buys time to recover from stalled or collapsed replication forks. Interestingly, the same checkpoint system also controls how DNA is replicated when stalled replication forks are detected. These latter responses, sometimes referred to as the intra-S checkpoint, do not meet the technical definition of a checkpoint. However, these responses are regulated by checkpoint proteins. Thus, the complete range of activities that are triggered by interrupted genome duplication is often called the replication checkpoint. This primer surveys the various manifestations of this checkpoint.
There are three main classes of checkpoint proteins: sensors that detect replication blocks or DNA damage; transducers that relay this signal; and effectors that act on targets of the checkpoint. The nomenclature of checkpoint proteins is complicated by the existence of multiple names for functional homologues from different organisms. Figure 1 shows 
Transducers
The keystone of the replication checkpoint is the DNA-dependent protein kinase-like family (DNA-PK) that includes human ATM and ATR, fission yeast Rad3 and budding yeast Mec1. These proteins are required for all DNA structure checkpoints in each organism and activate effector kinases by phosphorylation (see below). In yeasts, these proteins have regulatory subunits known as Rad26 in fission yeast and Lcd1/Ddc2/Cip1/Pie1 in budding yeast. Rad1, Hus1 and Rad9, three other proteins that are required for the replication and damage checkpoints, form a trimeric complex whose structure has been suggested to resemble the proliferating cell nuclear antigen, PCNA. PCNA is loaded onto DNA and acts as a sliding clamp that recruits replication factors to its exposed faces. The loading of PCNA onto DNA requires the concerted action of the replication factor C complex (RFC) composed of five subunits, RFCs1-5. Interestingly, another requisite factor for the replication checkpoint is Rad17, which resembles an RFC subunit and is found in complex with RFCs2-5. Therefore, it has been proposed that a complex containing Rad17 and RFCs2-5 loads the Rad1, Hus1 and Rad9 complex at sites of damage or blocked replication. The specific roles of these proteins in transducing the replication checkpoint signal is the subject of intense study.
Effectors
Downstream of the Rad3 homologues and the PCNA/RFC-like checkpoint proteins are the effector kinases. In fission yeast, Cds1 is the effector of the replication checkpoint and Chk1 mediates the G2-M DNA damage checkpoint. In budding yeast, the Cds1 functional homologue is called Rad53. In humans, two kinases, Cds1 (Chk2) and Chk1, are activated in response to replication disturbances. The role of human Chk1 in the replication checkpoint, in contrast to the G2-M role of Chk1 in fission yeast, is supported by data from Xenopus cell-free systems.
A common theme is that activation of the effector kinases is dependent on upstream DNA-PKlike proteins. Fission yeast Cds1 is phosphorylated on threonine 11 (T11) by Rad3 in vitro and T11 is critical for Cds1 activation in vitro. Activation of human Cds1 depends on phosphorylation of T68 by ATM in response to ionizing radiation, irrespective of cell cycle position. This activating phosphorylation may be carried out during S-phase in response to ultraviolet radiation and hydroxyurea by the ATM-related kinase ATR.
As described above, the DNA-PKlike protein kinases are required at the early steps of both the DNA replication and damage checkpoints. Until recently, how a signal emanating from a single upstream source could bifurcate and specifically activate the appropriate effector kinase presented a conundrum. That is, in fission yeast, Cds1 is specifically activated during Sphase by replication blocks, whereas Chk1 is activated in response to G2 DNA damage. In addition, neither Cds1 nor Chk1 change in abundance during the cell cycle and both proteins are in the nucleus during S-phase. This puzzle has recently been solved by the identification of an Sphase-specific adaptor protein. A protein called mediator of the replication checkpoint, Mrc1, was identified as a factor required for the S-phase-specific activation of Cds1 and Rad53. Mrc1 is expressed only during S-phase and thus serves as an ideal S-phase-specific adaptor. Mrc1 potentially recruits Cds1 to Rad3 for phosphorylation and activation. In support of this model, Cds1 has been found to interact with Mrc1. As mentioned above, in Xenopus the replication checkpoint requires Chk1. A Chk1 binding protein called Claspin was identified that is required for Chk1 activation during replication arrest. Claspin may play a similar adaptor protein role as Mrc1. Further studies are required to define exactly how Mrc1 and Claspin participate in the activation of the replication checkpoint effector kinases.
Replication checkpoint targets involved in cell cycle progression
Eukaryotic cells are driven into mitosis by the activity of the cyclindependent kinase, Cdc2. In most eukaryotes, the replication checkpoint maintains Cdc2 at an interphase level of activity, thus preventing cell cycle progression and entry into mitosis.
The activity of Cdc2 is attenuated by phosphorylation of a critical tyrosine residue (tyrosine 15 in S. pombe). This inhibitory phosphorylation is carried out by the tyrosine kinases Wee1 and Mik1. Cdc2 is activated by dephosphorylation of Y15, which is performed by the phosphatase Cdc25. The replication checkpoint keeps the Cdc2 Y15 residue phosphorylated by inactivating Cdc25 and increasing Y15-directed kinase activity. In fission yeast, Mik1 is expressed specifically during S-phase and the S-M checkpoint maintains Mik1 expression at a high level for the duration of the arrest. Thus, synthesis of the mitotic inhibitor Mik1 is coupled to DNA replication.
Intra-S-phase checkpoint
The role of Cds1 and Rad53 in arresting cell cycle progression has been well studied and described. Maybe the most intriguing aspects of Cds1 and Rad53 functions are only now being uncovered. In fission yeast, it has been shown that Cds1 plays a cell cycle arrest independent role in surviving replication blocks. In the absence of Cds1, replication blocks activate the G2-M checkpoint kinase, Chk1. Chk1 blocks cell cycle progression and entry into mitosis; however, cells die when they reenter the cell cycle. Therefore, Cds1 must act on other processes in addition to maintaining Cdc2 at an interphase level of activity. The
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Cdc2-independent role of Cds1 in surviving replication stress has been variously described as the recovery, tolerance or intra-S function.
The Mre11-Xrs2 (NBS1)-Rad50 complex
In mammalian cells, radiation induced DNA damage encountered during S-phase strongly delays the completion of DNA replication. It has been known for twenty years that cells from ataxia telangiectasia (AT) or Nijmegen breakage syndrome (NBS) patients, are defective in slowing progress through S-phase in response to DNA-damaging agents. This phenomenon was referred to as radiation-resistant DNA synthesis. More recently it has become apparent that AT and NBS cells are defective in the intra-S phase checkpoint. AT cells lack a functional ATM protein and are therefore defective in various checkpoint responses, including the intra-S checkpoint. NBS1 is part of a trimeric exonuclease complex containing MRE11, NBS1 and RAD50. NBS cells carry a mutation in the NBS1 component of this trimer that compromises the activity of the complex. It has recently been shown in budding yeast that MRE11, NBS1 and RAD50 -Mre11, Xrs2 and Rad50 respectively -are required for the intra-S phase checkpoint in response to DNA double strand breaks. Specifically, the exonuclease activity of Mre11 appears to be required. In the absence of the Mre11-Xrs2-Rad50 complex, activation of Rad53 in response to double strand breaks is compromised and the intra-S phase checkpoint is lost.
The Mre11-Xrs2-Rad50 complex is required for the processing of double strand breaks into substrates for either the homologous recombination (HR) or nonhomologous end joining (NHEJ) repair pathways. Mre11-Xrs2-Rad50 produces extensive regions of singlestranded DNA during exonucleolytic resection of double strand breaks, a form of DNA suggested to evoke potent checkpoint responses. However, loss of either or both recombinational repair pathways in yeast does not reduce Rad53 activation in response to double strand breaks. Therefore, loss of recombinational repair does not itself lead to a checkpoint deficiency. In addition, human cells with a hypomorphic MRE11 mutation display phenotypes similar to those of AT cells. These observations suggest that the Mre11-Xrs2-Rad50 complex has a direct role in sensing or modifying the double strand breaks to activate checkpoint responses.
Origin firing and fork progression
Studies in both fission and budding yeasts have established roles for Cds1 and Rad53 in controlling the rate of passage through S-phase in the presence of DNA damage. Wild-type cells, in the presence of DNA lesions, activate the checkpoint cascade and slow the rate of replication. However, cells mutated for Mec1/Rad3 or Rad53/Cds1 appear to complete replication with normal kinetics as judged by flow cytometry analysis of DNA content, as though no damage was present. Importantly, recent studies using higher resolution techniques to measure replication have shown that checkpoint mutants actually do not complete replication when forks are stalled.
In eukaryotes, replication proceeds from a number of replication origins in a temporal sequence during S-phase. Slow S-phase progression mediated by the checkpoint could be explained by a slowing of replication fork movement, the inhibition of late origin firing, or both. The Rad53-dependent checkpoint actively suppresses firing of late origins when replication from early origins is blocked. Recent studies in budding yeast have shown that the DNAalkylating agent methylmethane sulfonate slows the rate of replication fork movement equally in wild type or checkpoint mutants. However, the firing of late replicating origins was suppressed in wild type but not checkpoint mutants. These data suggest that in wild-type cells, slow Sphase progression in the presence of methylmethane sulfonate is a result of repressing late origin firing, in addition to a checkpoint-independent physical slowing of fork movement. The slow fork movement may result from an inherently slower form of replication, involving recombination or lesion bypass mechanisms induced by DNA damage.
Replication fork stabilization
A role for Mec1 and Rad53 in stabilizing stalled replication forks has recently been described in budding yeast. In cells treated with hydroxyurea or methylmethane sulfonate, early origins of replication fire but late origins are repressed by the checkpoint. And stalled forks are maintained in a replicationcompetent state by the checkpoint. When the block is removed, replication can usually continue without the need for elaborate replication restart mechanisms. In the absence of the checkpoint, stalled forks collapse and synthesis cannot continue from these forks.
How Rad53 stabilizes a stalled replication fork is unknown. Intriguingly, the phosphorylation states of various proteins involved in recombination pathways and normal S-phase progression are modulated by Rad53 and Cds1. It is possible that the checkpoint directly targets components of the replication machinery to maintain the replisome and fork in an open and competent structure (see Figure 1) . In support of this, the phosphorylation states of replication protein A (RPA) and polymerase-alpha primase B-subunit are regulated by the checkpoint. The Cdc7-Dbf4 kinase in budding yeast (Hsk1-Dfp1 in fission yeast) is required for the initiation of replication and appears to have a role throughout S-phase to maintain genomic stability. Both components of this kinase are modified in a checkpoint-dependent manner when replication is perturbed. The role of these modifications in tolerating Sphase blocks is unclear, but some evidence suggests that Hsk1 is negatively regulated by Cds1.
Regulation of recombination factors by the intra-S checkpoint
The replication checkpoint also regulates the phosphorylation state of proteins involved in recombination repair. In budding yeast, Rad55, a protein involved in homologous recombination, is a substrate of the replication checkpoint. In fission yeast, Mus81, a component of a nuclear Holliday junction resolving enzyme, binds to the checkpoint kinase Cds1. Mus81 is phosphorylated in a Cds1-dependent manner during S-phase and is hyperphosphorylated in response to replication arrest. Mus81 is required during S-phase for tolerating lesions that cause replication forks to stall.
In Escherichia coli, stalled replication forks can regress to form what has been called a 'chicken foot', a Holliday junction-like DNA structure. Evidence is mounting that replication fork regression also occurs in eukaryotes. The DNA helicase Rqh1, a member of the RecQ DNA helicase family, also acts downstream of Cds1 in a pathway parallel to Mus81, which allows survival of replication blocking lesions. Mammalian counterparts of Rqh1 called BLM and WRN are able to bind and translocate Holliday junctions in vitro. Based on the above observations it is possible that Rqh1 normally operates during S-phase to reverse regression at stalled forks, maintaining replication forks open and competent to resume replication (Figure 2 ). In the absence of Rqh1, Mus81 would cleave Holliday junctions formed at regressed forks to promote replication through a recombination-based mechanism (Figure 2 ). In support of this model, cells that are null for both Rqh1 and Mus81 are inviable. It will be exciting to determine how the function of these recombination repair proteins is influenced by Cds1 and Rad53.
Outlook
Replication of a eukaryotic genome involves many roadblocks that are removed or bypassed by a number of different mechanisms. It is becoming increasingly evident that checkpoint proteins orchestrate many of these events, while at the same time arresting cell cycle progression. In the future, we can look forward to understanding in much greater detail how the replication checkpoint maintains genome integrity. Many replication and repair factors appear to be substrates of checkpoint kinases, but there is scant evidence of how these proteins are regulated by phosphorylation. It will be fascinating to discover what proteins are recruited to stalled replication forks and how they prevent or correct fork collapse. Hopefully, advances in understanding the replication checkpoint responses will be accompanied by new insights into how stalled replication forks are detected by replication checkpoint sensors. With the recent convergence of replication checkpoint studies in several powerful model systems, we can look forward to rapid progress in this field.
